CIK 0000771856 · Non-accelerated filer<br>Smaller reporting company
CHAMPIONS ONCOLOGY, INC.
Sign in to watch- Ticker
- CSBR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Apr 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521401755
- Phone
- 410-369-0365
- Business address
- 855 N. WOLFE STREET, SUITE 619, BALTIMORE, MD, 21205
- Former names
- CHAMPIONS BIOTECHNOLOGY, INC., CHAMPIONS SPORTS INC
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Option exercise Director acquired 126,940 shares (option exercise)
- 4 Option exercise Director acquired 30,000 shares (option exercise)
- 4 Option exercise Director acquired 34,375 shares (option exercise)
- 4 Option exercise CEO acquired 126,940 shares (option exercise)
- 4 Option exercise Director acquired 10,000 shares (option exercise)
- 4 Option exercise Director acquired 16,667 shares (option exercise)
- 8-K Event Shareholder vote results
- 8-K Event Exhibits
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- DEFA14A Proxy Proxy Materials
- DEFM14A Deal DEFM14A
- DEF 14A Proxy Proxy Statement
- 10-K Report Annual Report
- 8-K Event Results of operations
- 8-K Event Unregistered share sale
- 4 Open-market buy Director bought 1,220 shares at an average $5.91 ($7,213)
- 4 Open-market buy Director bought 26 shares at $5.50 ($143)
Page 9 of 33 · 659 filings